This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation Mar. 21, 2012

Healthcare law challenge weighed by Supreme Court: What's at stake?
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two years after the president signed the Affordable Care Act, the justices of the Supreme Court are poised to weigh in with their opinions about the far-reaching act, with people across the country expectantly awaiting the outcome of the legal challenge. The court will consider over the course of three days several cases brought by 26 states and several private plaintiffs. Along the way, legal scholars, political figures, healthcare leaders and ordinary citizens have probed the constitutionality of the law's controversial requirement that virtually all Americans must purchase minimal health insurance coverage starting in 2014 or pay a tax penalty. More

Study measures cancer risk among women taking contraceptives
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women who have used injectable or oral birth control in the past are at a significantly higher relative risk of invasive breast cancer, but they are at significantly lower risk of ovarian cancer, according to a new study based on black women in South Africa. As more time passed after a woman stopped using the contraceptives, her increased risk diminished. The study, published in PLoS Medicine, pulled self-reported data from 5,702 participants with newly diagnosed invasive breast, cervical, ovarian or endometrial cancers. More

Researchers find possible genetic keys to surviving epithelial ovarian cancer
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the United States and the United Kingdom have used two genomewide association studies — one from the U.S. and one from the U.K. — to detect a novel set of genes found to be associated with epithelial ovarian cancer patient survival. The discovery could open the door to new therapies for treating epithelial ovarian cancer, the most lethal kind of gynecologic malignancy. More

It's About Time

Learn more about this follicular lymphoma treatment at the link below.

Computer-aided detection aids cancer testing, treatment
FierceHealthIT    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Computer-aided detection can help identify and treat cancer, new research suggests. According to the study, published in this month's American Journal of Roentgenology, CAD improved the likelihood for radiologists to identify cancer that initially went undetected during a screening. The study's authors said that radiologists failed to recognize a correct computer prompt in 70 percent of missed cancer cases. More

New cervical cancer screening guidelines include HPV tests
Time    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although infection with human papillomavirus, or HPV, is the leading cause of cervical cancer, until now, an influential government group has been reluctant to recommend using the HPV test to screen for the disease. That recently changed when the U.S. Preventive Services Task Force recommended that the HPV test is appropriate for some women as part of routine cervical cancer screening. More

ONCOCHART now in the cloud!

ONCOCHART, the 1st ARRA-certified RadOnc EMR, can be deployed either in a local environment or “cloud” environment. See us at ACRO Booth 21 for complete details.

Task force: Do cervical cancer tests less often
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women ages 21 to 29 should undergo cervical cancer screening with Pap tests every three years and then every five years with Pap and HPV tests until age 65, according to updated clinical guidelines. Women younger than 21 and most women older than 65 should not be screened, as data have shown that screening does not reduce cervical cancer incidence or mortality in those groups, the guidelines say. More

Trial suggests PSA testing still has value
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The controversy over prostate cancer screening seems likely to continue with publication of a major European trial that continues to show a benefit with routine testing in healthy men. After 11 years of follow-up, screening resulted in about a 21 percent reduction in the rate of prostate cancer deaths, Dr. Fritz Schröder, of Erasmus University Medical Center in Rotterdam, the Netherlands, and colleagues reported in the March 15 issue of the New England Journal of Medicine. More

Catalyst - Reinforcing the Treatment Chain
Improve patient throughput whilst ensuring patient safety. The Catalyst is an optical scanner which creates a 3D model of the patient surface and projects positional delta directly onto the patient providing continual feedback for the Therapist. Movement during the fraction is detected triggering a visual and audible alarm. more

CDC launches graphic new anti-smoking campaign
Time    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health officials have announced a graphic anti-smoking campaign designed to jolt Americans into putting out their cigarettes. The national advertising campaign will include billboards and print, TV, radio and online ads showing Americans whose smoking has caused dire health consequences, including amputation, tracheotomy, paralysis and heart surgery. More

Experts: Breast cancer on the rise among African women
Voice of America    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A breast cancer advocate says African women are becoming increasingly vulnerable to the disease. Ify Nwabukwu is the founder of the Washington-based African Women Cancer Awareness Association. "Breast cancer currently is presenting very early among African women here and back home in Africa," she says. "The disease is more aggressive in Africans than any other group." For years, breast cancer was thought of as a disease of the developed world. But health experts say incidence of the disease is increasing in the developing world. More
RadOnc Weekly
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Patrick McCoy, Senior Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to %%emailaddr%%. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
March 14, 2012
March 7, 2012
Feb. 29, 2012
Feb. 22, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063